BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240604T130000
DTEND;TZID=America/Halifax:20240604T140000
DTSTAMP:20260521T185704
CREATED:20240520T125843Z
LAST-MODIFIED:20241024T183043Z
UID:10000762-1717506000-1717509600@staging.digitalinsights.supremeclients.com
SUMMARY:HGMD Pro in action: Search\, curate and classify genetic variants - Session 1
DESCRIPTION:In this live\, interactive training session\, our technical expert will show you how the Human Gene Mutation Database (HGMD) Professional can help you get better variant data faster.\n\nYou will learn how to:\n• Differentiate between clinically significant variants and variants of unknown significance (VUS)\n• Use batch search vs. advanced search\, including their differences\n• Curate genes using HGMD Pro’s accurate\, up-to-date information\n• Determine the predominant type of genetic variant that occurs in a specific gene to understand the genetic mechanisms underlying associated diseases\n• Additional topics of interest based on registration feedback
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/hgmd-pro-in-action-search-curate-and-classify-genetic-variants-session-1/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1158_7_QCI_HGMD_GI1185643368_Large-1200px_59468.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240606T130000
DTEND;TZID=America/New_York:20240606T140000
DTSTAMP:20260521T185704
CREATED:20240326T112228Z
LAST-MODIFIED:20241024T183032Z
UID:10000743-1717678800-1717682400@staging.digitalinsights.supremeclients.com
SUMMARY:Investigating genomic variants using QIAGEN CLC Genomics Workbench\, QCI Interpret Translational (QCIIT)\, and QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:Discovering new genes implicated in hereditary diseases or cancer progression is challenging yet advancing rapidly due to the increase in next-generation sequencing (NGS) cohort data. These data analyses produce insights into associations between gene variants and diseases and the biological mechanisms of these gene variants. \nBy combining QIAGEN CLC Genomics Workbench\, QCIIT and QIAGEN IPA\, you can analyze sequencing data obtained from a variety of NGS technologies\, annotate gene variants using the world’s most comprehensive and up-to-date curated scientific evidence and find biological connections in gene variants with manually curated scientific findings. Using a streamlined NGS analysis workflow\, you’ll get valuable and reliable insights for your research project and speed up your discoveries. \nIn this training\, you’ll: \n\nLearn to import whole genome or exome sequencing data into QIAGEN CLC Genomics Workbench and use the ultra-fast LightSpeed Module that delivers an end-to-end NGS FASTQ to VCF pipeline\nExplore the capabilities in QCIIT which can help accelerate your discoveries from hereditary or tumor cohort analyses to find associations between gene variants and diseases\nLearn how to use QIAGEN IPA and its manually curated content\, among other integrated scientific evidence\, to uncover novel biological mechanisms underlying these gene variants
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/investigating-genomic-variants-using-qiagen-clc-genomics-workbench-qci-interpret-translational-qcii-t-and-qiagen-ingenuity-pathway-analysis-ipa-3/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1327_8_QDI_QCI_Hereditary_Gi1346512014.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240606T130000
DTEND;TZID=America/New_York:20240606T143000
DTSTAMP:20260521T185704
CREATED:20240416T171125Z
LAST-MODIFIED:20241024T183034Z
UID:10000750-1717678800-1717684200@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN Ingenuity Pathway Analysis (IPA) new user training
DESCRIPTION:Large dataset analysis and exploring the knowledge base using QIAGEN Ingenuity Pathway Analysis (IPA) \nJoin us for a 120-minute training session for new users of QIAGEN IPA. \nIn this training\, you’ll learn how to: \n• Upload your dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more) and perform interactive core/pathway analysis in IPA\n• Understand the different result types produced (pathways\, key regulators\, impact on biological functions/diseases and more)\n• Compare different experimental conditions (treatments\, time points\, single-cell clusters\, disease types and more) and identify similarities and contrasts\n• Generate a network even without a dataset or experimental design for hypothesis generation \nFor those with IPA licenses: download the installer from the link below to install IPA before or after the training.\nhttps://qiagen.showpad.com/share/CBv30blCPKFDUYHRWtAvI \nTo learn more about IPA or request a trial: https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-ipa/?cmpid=CM_QDI_DISC_042024webinars-NUT
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ingenuity-pathway-analysis-ipa-new-user-training-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240611T130000
DTEND;TZID=America/Halifax:20240611T140000
DTSTAMP:20260521T185704
CREATED:20240520T124917Z
LAST-MODIFIED:20241024T183043Z
UID:10000761-1718110800-1718114400@staging.digitalinsights.supremeclients.com
SUMMARY:Geneset enrichment\, target Validation and more through programmatically utilizing high quality biomedical literature findings
DESCRIPTION:In this 60-minute session\, the trainer will go over how to effectively utilize a relationship database for below applications. In this case\, QIAGEN Biomedical Knowledgebase (Biomedical KB – a database containing high-quality relationship literature findings\, the same database backing Ingenuity Pathway Analysis/IPA) will be used\, but learning can possibly be applied to similar databases as well.\nThe trainer/QIAGEN team will go over\n• Conducting Geneset Enrichment Analysis (GSEA)\n• How multiple Geneset enrichment methods can be used instead of only those integrated in software GUI\n• Target Validation at cell\, tissue\, and organ level\n• Potentially other use cases\, queries\, and applications requested by registrants \nLearn more about Biomedical KB: https://qiagen.showpad.com/share/GmpIJaN5kRfsHRD5WPwgc
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/geneset-enrichment-target-validation-and-more-through-programmatically-utilizing-high-quality-biomedical-literature-findings/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1212_7_QDI_QDI_BKB_Original_59173.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240612T100000
DTEND;TZID=America/Halifax:20240612T113000
DTSTAMP:20260521T185704
CREATED:20240611T152929Z
LAST-MODIFIED:20241024T183047Z
UID:10000770-1718186400-1718191800@staging.digitalinsights.supremeclients.com
SUMMARY:How is AI Changing Pharma R&D?
DESCRIPTION:AI has begun to transform and accelerate every step of the drug development lifecycle from target identification to drug discovery and clinical trial design. However\, the rapid development and adoption of AI platforms come with its own set of challenges regarding data quality\, data privacy\, and an evolving regulatory landscape. Panelists in this webinar will share their insights into the major opportunities and challenges facing biopharma leaders today as they continue to evaluate and incorporate new AI tools into their R&D workflows.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-is-ai-changing-pharma-rd/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/CILLU_0243_QDI_QDI_BKB_Generic.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240613T130000
DTEND;TZID=America/Halifax:20240613T140000
DTSTAMP:20260521T185704
CREATED:20240520T130441Z
LAST-MODIFIED:20241024T183044Z
UID:10000764-1718283600-1718287200@staging.digitalinsights.supremeclients.com
SUMMARY:How decentralized and small labs can adopt high-throughput NGS analysis with limited time and resource investment
DESCRIPTION:Next-generation sequencing (NGS) has rapidly gained popularity as a diagnostic testing approach due to its unparalleled ability to comprehensively analyze genetic information with high throughput and precision. However\, decentralized and small labs face significant hurdles when it comes to adopting NGS testing. From high upfront costs associated with acquiring the necessary equipment\, to the complexity of bioinformatics tools and compliance management that require specialized expertise in data analysis and data security\, adopting NGS poses challenges for labs with limited staff and infrastructure. \nTo empower small and decentralized labs to easily adopt NGS testing\, QIAGEN has launched a new secondary analysis solution for oncology and inherited disease applications that enables high-throughput secondary analysis for use with any clinical NGS data. In this webinar\, learn about QCI Secondary Analysis\, an agnostic\, cloud-based software-as-a-service (SaaS) solution that seamlessly integrates with QCI Interpret\, QIAGEN’s clinical variant interpretation and reporting software\, to deliver highly scalable and customizable Sample to Insight workflows for oncology and inherited disease applications. \nIn this webinar\, attendees will learn how QCI Secondary Analysis: \n\nStreamlines analysis from a range of assay types\, enabling labs to process more sequencing data without extensive time and resource investment.\nEnsures the highest degree of isolation and data protection\, including compliance with ISO 27001\, General Data Protect Regulation (GDPR)\, and the Health Insurance Portability and Accountability Act (HIPPA) requirements.\nDirectly connects to QCI Interpret for an integrated and automated FASTQ-to-report workflow with limited hands-on time.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-decentralized-and-small-labs-can-adopt-high-throughput-ngs-analysis-with-limited-time-and-resource-investment/
LOCATION:Virtual Global Event (Times shown in EST)
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1306_4_QDI_QCI_SecondaryAnalysis_Gi841410132-5.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240613T130000
DTEND;TZID=America/Halifax:20240613T140000
DTSTAMP:20260521T185704
CREATED:20240523T052050Z
LAST-MODIFIED:20241024T183044Z
UID:10000765-1718283600-1718287200@staging.digitalinsights.supremeclients.com
SUMMARY:Accelerating Drug Discovery with Comprehensive Curated Knowledge
DESCRIPTION:In the rapidly evolving landscape of drug discovery\, the ability to integrate high-quality research findings into knowledge graphs is paramount. For over twenty years\, the Ingenuity team with QIAGEN has curated these nodes and relationships. Our QIAGEN Biomedical KB-HD make these data available for consumption outside of Ingenuity Pathway Analysis. \nIn this talk\, we will: \n• Explore how to query and leverage this curated data resource to accelerate the drug discovery process.\n• Provide live demonstration of the underlying database Biomedical-HD\n• Show how the Biomedical KB-HD can be rapidly deployed\n• Show how the underlying schema and ontologies could serve as a scaffold for integrating your own research \nOverall\, this demonstration will show the critical role of knowledge graphs in predicting adverse outcomes and toxicity\, highlighting their transformative potential in steering pharmaceutical research and development. \nLearn more about Biomedical KB: https://qiagen.showpad.com/share/GmpIJaN5kRfsHRD5WPwgc
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/accelerating-drug-discovery-with-comprehensive-curated-knowledge/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1212_9_QDI_QDI_BKB_Original_61828_16x9_62947_Large-1200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240618T130000
DTEND;TZID=America/Halifax:20240618T140000
DTSTAMP:20260521T185704
CREATED:20240520T130124Z
LAST-MODIFIED:20241024T183044Z
UID:10000763-1718715600-1718719200@staging.digitalinsights.supremeclients.com
SUMMARY:HGMD Pro in action: Search\, curate and classify genetic variants - Session 2
DESCRIPTION:In this live\, interactive training session\, our technical expert will show you how the Human Gene Mutation Database (HGMD) Professional can help you get better variant data faster.\n\nYou will learn how to:\n• Differentiate between clinically significant variants and variants of unknown significance (VUS)\n• Use batch search vs. advanced search\, including their differences\n• Curate genes using HGMD Pro’s accurate\, up-to-date information\n• Determine the predominant type of genetic variant that occurs in a specific gene to understand the genetic mechanisms underlying associated diseases\n• Additional topics of interest based on registration feedback
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/hgmd-pro-in-action-search-curate-and-classify-genetic-variants-session-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1158_7_QCI_HGMD_GI1185643368-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240618T130000
DTEND;TZID=America/Halifax:20240618T140000
DTSTAMP:20260521T185704
CREATED:20240808T095719Z
LAST-MODIFIED:20241024T182400Z
UID:10000563-1718715600-1718719200@staging.digitalinsights.supremeclients.com
SUMMARY:HGMD Pro in action: Search\, curate and classify genetic variants - Session 2
DESCRIPTION:In this live\, interactive training session\, our technical expert will show you how the Human Gene Mutation Database (HGMD) Professional can help you get better variant data faster.\n\nYou will learn how to:\n• Differentiate between clinically significant variants and variants of unknown significance (VUS)\n• Use batch search vs. advanced search\, including their differences\n• Curate genes using HGMD Pro’s accurate\, up-to-date information\n• Determine the predominant type of genetic variant that occurs in a specific gene to understand the genetic mechanisms underlying associated diseases\n• Additional topics of interest based on registration feedback
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/hgmd-pro-in-action-search-curate-and-classify-genetic-variants-session-2-2/
LOCATION:HSMD-screen-grab-2
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1158_7_QCI_HGMD_GI1185643368-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240618T130000
DTEND;TZID=America/Halifax:20240618T143000
DTSTAMP:20260521T185705
CREATED:20240606T041818Z
LAST-MODIFIED:20241024T183045Z
UID:10000768-1718715600-1718721000@staging.digitalinsights.supremeclients.com
SUMMARY:Leveraging the QIAGEN Knowledge Graph and causal embeddings for insights into drug repurposing
DESCRIPTION:By connecting diverse entities and relationships\, biomedical knowledge graphs hold the potential to uncover new insights from existing data. This webinar introduces a machine learning-based approach that utilizes causal interactions from the QIAGEN Knowledge Graph to predict novel drug-disease relationships and construct networks that capture relevant supporting evidence. We will present examples that showcase the application of this approach in the context of drug repurposing.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/leveraging-the-qiagen-knowledge-graph-and-causal-embeddings-for-insights-into-drug-repurposing/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1212_7_QDI_QDI_BKB_Original_59173.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240618T130000
DTEND;TZID=America/Halifax:20240618T143000
DTSTAMP:20260521T185705
CREATED:20240808T095718Z
LAST-MODIFIED:20241024T182401Z
UID:10000562-1718715600-1718721000@staging.digitalinsights.supremeclients.com
SUMMARY:Leveraging the QIAGEN Knowledge Graph and causal embeddings for insights into drug repurposing
DESCRIPTION:By connecting diverse entities and relationships\, biomedical knowledge graphs hold the potential to uncover new insights from existing data. This webinar introduces a machine learning-based approach that utilizes causal interactions from the QIAGEN Knowledge Graph to predict novel drug-disease relationships and construct networks that capture relevant supporting evidence. We will present examples that showcase the application of this approach in the context of drug repurposing.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/leveraging-the-qiagen-knowledge-graph-and-causal-embeddings-for-insights-into-drug-repurposing-2/
LOCATION:HSMD-screen-grab-2
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1212_7_QDI_QDI_BKB_Original_59173-4.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240620T130000
DTEND;TZID=America/Halifax:20240620T150000
DTSTAMP:20260521T185705
CREATED:20240523T052728Z
LAST-MODIFIED:20241024T183044Z
UID:10000766-1718888400-1718895600@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN Ingenuity Pathway Analysis (IPA) for grant writing and publications with new features
DESCRIPTION:QIAGEN Ingenuity Pathway Analysis (IPA) is more than just an analysis program; it can also help you write grants and publications. IPA provides biological insights backed by expert-curated findings and thousands of pre-analyzed multiomics datasets. You can search for existing knowledge on molecules of interest\, build networks and review results from public studies. Or you can identify key pathways\, regulatory molecules and functional changes in your results and see how your data relates to published studies. \nJoin us to learn how to: \n• Search IPA’s vast collection of curated literature and omics data\n• Relate molecules to phenotypes and functions\n• Build your own networks and predict activity changes\n• Explore a library of over 90\,000 precomputed IPA analyses pulled from publicly available studies\n• Format your dataset and set up an analysis\n• Deeply interrogate key Canonical Pathways\n• Predict regulators causing your observed expression changes\n• Contextualize your results by comparing them to internal and public data\n• Generate the necessary tables and figures for your manuscript \nDo you already have an IPA license? Install IPA and start using it now: https://qiagen.showpad.com/share/CBv30blCPKFDUYHRWtAvI \nLearn more about IPA or request a free trial: https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-ipa/
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ingenuity-pathway-analysis-ipa-for-grant-writing-and-publications-with-new-features-3/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1062_0_IPA_Challenger_029613_16x9_Large-1200px_54798.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240625T130000
DTEND;TZID=America/Halifax:20240625T143000
DTSTAMP:20260521T185705
CREATED:20240523T053239Z
LAST-MODIFIED:20241024T183045Z
UID:10000767-1719320400-1719325800@staging.digitalinsights.supremeclients.com
SUMMARY:RNA-seq data analysis and interpretation with sankey plot update
DESCRIPTION:For RNA-seq data\, you will learn how to: \n• Import FASTQ files\, cell matrix files and metadata and how to download references\n• Map reads to a reference genome and generate gene and transcript counts and QC reports displaying % mapped reads\, knee plots\, etc.\n• Generate visualizations of results\, such as heatmaps\, differential expression tables\, PCA/PCOA plots\, Venn diagrams\, sankey plot and others\n• Easily customize RNA-seq workflows\n• Export publication-quality graphics\, tables and reports\n• Send differential expression tables to QIAGEN Ingenuity Pathway Analysis directly from QIAGEN CLC Genomics Workbench to analyze and interpret relevant pathways \nLearn more about CLC or request a free trial: https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-clc-workbench-premium/
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/rna-seq-data-analysis-and-interpretation-with-sankey-plot-update-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1004_3_QDI_CLCPHLpackage_Gi537315268_16x9_Medium-720px_51280.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240627T130000
DTEND;TZID=America/Halifax:20240627T140000
DTSTAMP:20260521T185705
CREATED:20240610T163717Z
LAST-MODIFIED:20241024T183045Z
UID:10000769-1719493200-1719496800@staging.digitalinsights.supremeclients.com
SUMMARY:Benefits of integrating targeted next-generation sequencing (NGS) panels into molecular diagnostics of solid tumors
DESCRIPTION:Variant detection of multiple genes from a single tumor sample requires high-throughput molecular testing. To meet this demand\, targeted next-generation sequencing (NGS) panels are useful in clinical settings for accurate tumor profiling and the identification of essential molecular aberrations for personalized therapies. By focusing only on a subset of genes\, targeted NGS is not only a cost-effective solution\, but can rapidly deliver insights into a tumor molecular profile. \nTo address this challenge\, a clinical research team led by Dr. Michela Bulfoni at the Istituto di Anatomia Patologica designed custom NGS panels\, named “Glioma” and “Routine Diagnostics”\, targeting single nucleotide variations\, insertions/deletions\, fusions\, and copy number variations of tumor-associated essential genes. \nIn this webinar\, attendees will:\nUnderstand the clinical utility of custom-designed NGS panels for accurate tumour diagnosis\nLearn about the design and application of these NGS panels\nGain insights into the cost-effectiveness and high sensitivity of NGS panels in improving sample throughput
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/benefits-of-integrating-targeted-next-generation-sequencing-ngs-panels-into-molecular-diagnostics-of-solid-tumors/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1314_3_QDI_QCI_SampletoInsight_Oncology_GI1388388119.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240627T130000
DTEND;TZID=America/Halifax:20240627T140000
DTSTAMP:20260521T185705
CREATED:20240808T095718Z
LAST-MODIFIED:20241024T182402Z
UID:10000561-1719493200-1719496800@staging.digitalinsights.supremeclients.com
SUMMARY:Benefits of integrating targeted next-generation sequencing (NGS) panels into molecular diagnostics of solid tumors
DESCRIPTION:Variant detection of multiple genes from a single tumor sample requires high-throughput molecular testing. To meet this demand\, targeted next-generation sequencing (NGS) panels are useful in clinical settings for accurate tumor profiling and the identification of essential molecular aberrations for personalized therapies. By focusing only on a subset of genes\, targeted NGS is not only a cost-effective solution\, but can rapidly deliver insights into a tumor molecular profile. \nTo address this challenge\, a clinical research team led by Dr. Michela Bulfoni at the Istituto di Anatomia Patologica designed custom NGS panels\, named “Glioma” and “Routine Diagnostics”\, targeting single nucleotide variations\, insertions/deletions\, fusions\, and copy number variations of tumor-associated essential genes. \nIn this webinar\, attendees will:\nUnderstand the clinical utility of custom-designed NGS panels for accurate tumour diagnosis\nLearn about the design and application of these NGS panels\nGain insights into the cost-effectiveness and high sensitivity of NGS panels in improving sample throughput
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/benefits-of-integrating-targeted-next-generation-sequencing-ngs-panels-into-molecular-diagnostics-of-solid-tumors-2/
LOCATION:HSMD-screen-grab-2
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1314_3_QDI_QCI_SampletoInsight_Oncology_GI1388388119-1.jpg
END:VEVENT
END:VCALENDAR